Abstract

Mini Review

Teledentistry and Digital Therapeutics (DTx) for dentistry

Sang-Yoon Park*

Published: 05 August, 2022 | Volume 6 - Issue 1 | Pages: 028-030

Due to the global pandemic spread of COVID-19, the medical field has experienced many changes [1]. One of the main changes is the attention to Telemedicine (Digital Medicine), which is a part of Digital Health. The combination of ‘Digital’ and ‘Dentistry’ can be awkward because dental treatment is often conducted face-to-face with clinical treatment, but it is planned to proceed with the inevitable flow of the times [2,3]. In addition, Digital therapeutics (DTx), a part of digital dentistry, is a narrower concept and has an evidence-based effect on diseases. This article contains opinions on the concept and current status of Teledentistry and the application of DTx [4].

Read Full Article HTML DOI: 10.29328/journal.jcad.1001029 Cite this Article Read Full Article PDF

References

  1. Shashi B. Telemedicine technologies for confronting COVID-19 pandemic: A review. Journal of Industrial Integration and Management. 2020; 5: 547-561.
  2. Ghai S. Teledentistry during COVID-19 pandemic. Diabetes Metab Syndr. 2020 Sep-Oct;14(5):933-935. doi: 10.1016/j.dsx.2020.06.029. Epub 2020 Jun 16. PMID: 32593116; PMCID: PMC7297180.
  3. Rahman N, Nathwani S, Kandiah T. Teledentistry from a patient perspective during the coronavirus pandemic. Br Dent J. 2020 Aug 14:1–4. doi: 10.1038/s41415-020-1919-6. Epub ahead of print. PMID: 32801323; PMCID: PMC7427495.
  4. Minervini G, Russo D, Herford AS, Gorassini F, Meto A, D'Amico C, Cervino G, Cicciù M, Fiorillo L. Teledentistry in the Management of Patients with Dental and Temporomandibular Disorders. Biomed Res Int. 2022 Apr 9;2022:7091153. doi: 10.1155/2022/7091153. PMID: 35437507; PMCID: PMC9013296.
  5. Abbadessa G, Lavorgna L, Miele G, Mignone A, Signoriello E, Lus G, Clerico M, Sparaco M, Bonavita S. Assessment of Multiple Sclerosis Disability Progression Using a Wearable Biosensor: A Pilot Study. J Clin Med. 2021 Mar 10;10(6):1160. doi: 10.3390/jcm10061160. PMID: 33802029; PMCID: PMC8001885.
  6. Lavorgna L, Iaffaldano P, Abbadessa G, Lanzillo R, Esposito S, Ippolito D, Sparaco M, Cepparulo S, Lus G, Viterbo R, Clerico M, Trojsi F, Ragonese P, Borriello G, Signoriello E, Palladino R, Moccia M, Brigo F, Troiano M, Tedeschi G, Bonavita S. Disability assessment using Google Maps. Neurol Sci. 2022 Feb;43(2):1007-1014. doi: 10.1007/s10072-021-05389-7. Epub 2021 Jun 17. Erratum in: Neurol Sci. 2021 Nov 2;: PMID: 34142263; PMCID: PMC8211455.
  7. Ricciardi D, Casagrande S, Iodice F, Orlando B, Trojsi F, Cirillo G, Clerico M, Bozzali M, Leocani L, Abbadessa G, Miele G, Tedeschi G, Bonavita S, Lavorgna L; Digital Technologies, Web, Social Media Study Group of the Italian Society of Neurology. Myasthenia gravis and telemedicine: a lesson from COVID-19 pandemic. Neurol Sci. 2021 Dec;42(12):4889-4892. doi: 10.1007/s10072-021-05566-8. Epub 2021 Aug 26. PMID: 34436726; PMCID: PMC8390022.
  8. Defining Digital Medicine. Digital Medicine Society (DiMe). Retrieved 2021-12-21.
  9. Join DTA.
  10. Kvedar JC, Fogel AL, Elenko E, Zohar D. Digital medicine's march on chronic disease. Nat Biotechnol. 2016 Mar;34(3):239-46. doi: 10.1038/nbt.3495. PMID: 26963544.
  11. Todd H. Digital Therapeutics Have Huge Promise And They Are Real Today. Forbes. 2015.
  12. Webb TL, Joseph J, Yardley L, Michie S. Using the internet to promote health behavior change: a systematic review and meta-analysis of the impact of theoretical basis, use of behavior change techniques, and mode of delivery on efficacy. J Med Internet Res. 2010 Feb 17;12(1):e4. doi: 10.2196/jmir.1376. PMID: 20164043; PMCID: PMC2836773.
  13. Elliott WJ, Izzo JL Jr. Device-guided breathing to lower blood pressure: case report and clinical overview. MedGenMed. 2006 Aug 1;8(3):23. PMID: 17406163; PMCID: PMC1781326.
  14. Kario K, Nomura A, Harada N, Tanigawa T, So R, Nakagawa K, Suzuki S, Okura A, Hida E, Satake K. A multicenter clinical trial to assess the efficacy of the digital therapeutics for essential hypertension: Rationale and design of the HERB-DH1 trial. J Clin Hypertens (Greenwich). 2020 Sep;22(9):1713-1722. doi: 10.1111/jch.13993. Epub 2020 Aug 20. PMID: 32815648; PMCID: PMC7589405.
  15. Kario K, Nomura A, Harada N, Okura A, Nakagawa K, Tanigawa T, Hida E. Efficacy of a digital therapeutics system in the management of essential hypertension: the HERB-DH1 pivotal trial. Eur Heart J. 2021 Oct 21;42(40):4111-4122. doi: 10.1093/eurheartj/ehab559. PMID: 34455443; PMCID: PMC8530534.
  16. Nordyke RJ, Appelbaum K, Berman MA. Estimating the Impact of Novel Digital Therapeutics in Type 2 Diabetes and Hypertension: Health Economic Analysis. J Med Internet Res. 2019 Oct 9;21(10):e15814. doi: 10.2196/15814. PMID: 31599740; PMCID: PMC6914106.
  17. Cymerys Ed; Duffy, Sean. Implementing USPSTF Recommendations on Behavioral Counseling for Cardiovascular Disease. Health Watch. 2015.
  18. Shuren J, Doraiswamy PM. Digital Therapeutics for MCI and Alzheimer's disease: A Regulatory Perspective - Highlights From The Clinical Trials on Alzheimer's Disease conference (CTAD). J Prev Alzheimers Dis. 2022;9(2):236-240. doi: 10.14283/jpad.2022.28. PMID: 35542995; PMCID: PMC8920745.
  19. Pinto MD, Greenblatt AM, Hickman RL, Rice HM, Thomas TL, Clochesy JM. Assessing the Critical Parameters of eSMART-MH: A Promising Avatar-Based Digital Therapeutic Intervention to Reduce Depressive Symptoms. Perspect Psychiatr Care. 2016 Jul;52(3):157-68. doi: 10.1111/ppc.12112. Epub 2015 Mar 19. PMID: 25800698.
  20. Stephanie B. Digitizing substance abuse treatment and recovery. Med City News. 2016.
  21. Kühnisch J, Meyer O, Hesenius M, Hickel R, Gruhn V. Caries Detection on Intraoral Images Using Artificial Intelligence. J Dent Res. 2022 Feb;101(2):158-165. doi: 10.1177/00220345211032524. Epub 2021 Aug 20. PMID: 34416824; PMCID: PMC8808002.
  22. Behnam A. Smartphone-Based Method for Detecting Periodontal Disease. 2019 IEEE Healthcare Innovations and Point of Care Technologies, (HI-POCT). IEEE, 2019.
  23. Sung-Jae L. Early detection of tongue cancer using a convolutional neural network and evaluation of the effectiveness of Efficient Net. 2022.
  24. Morikawa T, Kozakai A, Kosugi A, Bessho H, Shibahara T. Image processing analysis of oral cancer, oral potentially malignant disorders, and other oral diseases using optical instruments. Int J Oral Maxillofac Surg. 2020 Apr;49(4):515-521. doi: 10.1016/j.ijom.2019.08.016. Epub 2019 Sep 7. PMID: 31500953.
  25. Lord SE, Campbell ANC, Brunette MF, Cubillos L, Bartels SM, Torrey WC, Olson AL, Chapman SH, Batsis JA, Polsky D, Nunes EV, Seavey KM, Marsch LA. Workshop on Implementation Science and Digital Therapeutics for Behavioral Health. JMIR Ment Health. 2021 Jan 28;8(1):e17662. doi: 10.2196/17662. PMID: 33507151; PMCID: PMC7878106.
  26. Amantini SNSR, Montilha AAP, Antonelli BC, Leite KTM, Rios D, Cruvinel T, Lourenço Neto N, Oliveira TM, Machado MAAM. Using Augmented Reality to Motivate Oral Hygiene Practice in Children: Protocol for the Development of a Serious Game. JMIR Res Protoc. 2020 Jan 17;9(1):e10987. doi: 10.2196/10987. PMID: 31951216; PMCID: PMC6996757.
  27. Patel NA, Butte AJ. Characteristics and challenges of the clinical pipeline of digital therapeutics. NPJ Digit Med. 2020 Dec 11;3(1):159. doi: 10.1038/s41746-020-00370-8. PMID: 33311567; PMCID: PMC7733514.
  28. Wiederhold BK. Data-Driven Digital Therapeutics: The Path Forward. Cyberpsychol Behav Soc Netw. 2021 Oct;24(10):631-632. doi: 10.1089/cyber.2021.29227.editorial. Epub 2021 Sep 22. PMID: 34551264.
  29. Guidance with Digital Health Content. USFDA.

Figures:

Similar Articles

Recently Viewed

Read More

Most Viewed

Read More

Help ?